Bahija Jallal's most recent trade in Elevance Health Inc was a trade of 601 Common Stock done . Disclosure was reported to the exchange on May 14, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Elevance Health Inc | Bahija Jallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 601 | 4,788 (0%) | 0% | 0 | Common Stock | |
Immunocore Holdings plc - ADR | Bahija Jallal | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2025 | 405,824 | 405,824 | - | - | Employee Share Option (Right to Buy) | |
Immunocore Holdings plc - ADR | Bahija Jallal | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2025 | 95,270 | 95,270 | - | - | Restricted Share Units | |
Elevance Health Inc | Bahija Jallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 388 | 4,187 (0%) | 0% | 0 | Common Stock | |
Immunocore Holdings plc - ADR | Bahija Jallal | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 281,819 | 281,819 | - | - | Employee Share Option (Right to Buy) | |
ArriVent BioPharma Inc. | Bahija Jallal | Director | 25 Jan 2024 | 17,884 | 17,884 | - | - | Stock Option (right to buy) | ||
Elevance Health Inc | Bahija Jallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 457 | 3,799 (0%) | 0% | 0 | Common Stock | |
Guardant Health Inc | Bahija Jallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 1,814 | 0 | - | - | RESTRICTED STOCK UNITS | |
Guardant Health Inc | Bahija Jallal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2022 | 1,814 | 7,408 (0%) | 0% | 0 | COMMON STOCK | |
Elevance Health Inc | Bahija Jallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 440 | 3,342 (0%) | 0% | 0 | Common Stock | |
Guardant Health Inc | Bahija Jallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 3,135 | 3,135 | - | - | STOCK OPTION (RIGHT TO BUY) | |
Guardant Health Inc | Bahija Jallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 1,814 | 1,814 | - | - | RESTRICTED STOCK UNITS | |
Elevance Health Inc | Bahija Jallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 493 | 2,902 (0%) | 0% | 0 | Common Stock | |
Guardant Health Inc | Bahija Jallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 4,840 | 4,840 | - | - | STOCK OPTION (RIGHT TO BUY) | |
Guardant Health Inc | Bahija Jallal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2020 | 2,757 | 5,594 (0%) | 0% | 0 | COMMON STOCK |